XML 54 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule Of Assumptions In Determining The Fair Value Of Shares Issued Under The Employee Stock Purchase Plan
In determining the fair value of the right to purchase under the Employee Stock Purchase Plan, the Company uses the Black-Scholes option pricing model that employs the following key assumptions:
 Employee Stock Purchase Plan
Years Ended September 30,
 202320222021
Risk-free interest rate
3.18% - 4.90%
0.05% - 0.62%
0.07% - 0.13%
Expected dividend— — — 
Expected term0.5 years0.5 years0.5 years
Expected volatility
33.02% - 38.15%
26.34% - 31.57%
29.67% - 37.22%
Schedule Of Summary Of Restricted Stock Unit Activity
A summary of restricted stock unit activity under the Plan is as follows:
Performance Stock UnitsRestricted Stock Units
Outstanding
Performance
Stock Units
Weighted
Average
Grant Date
Fair Value
Outstanding
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Balance, September 30, 2022208,116 $169.99 1,137,619 $184.59 
Units granted131,491 145.02 1,448,427 145.10 
Units vested(92,677)144.69 (1,113,259)147.10 
Units cancelled(47,012)171.07 (247,401)162.80 
Balance, September 30, 2023199,918 $159.37 1,225,386 $156.89 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions In determining the fair value of the portion of the performance awards based on Total Shareholder Return, the Company uses a Monte Carlo simulation model that employs the following key assumptions:
Expected Volatility
Fair ValueExpected TermRisk-FreeIndexExpected
Grant Dateper Share(in years)Interest RateF5MembersDividend
November 1, 2022
Tranche 1$157.36 0.914.66 %37.17 %35.56 %— 
Tranche 2$173.68 1.914.51 %31.84 %31.74 %— 
Tranche 3$194.41 2.914.44 %35.50 %40.59 %— 
Schedule of Nonvested Restricted Stock Units Activity
As of September 30, 2023, the following annual equity grants for executive officers or a portion thereof are outstanding:
Grant DateRSUs GrantedVesting ScheduleVesting PeriodDate Fully Vested
November 1, 2022240,808
Quarterly, Annually1,2
3 yearsNovember 1, 2025
November 1, 2021160,384
Quarterly, Annually1,2
3 yearsNovember 1, 2024
November 2, 2020257,568
Quarterly, Annually1
3 yearsNovember 1, 2023
November 1, 2019228,616
Quarterly, Annually1
3 yearsNovember 1, 2022
(1)50% of the annual equity grant vests in equal quarterly increments and 50% is subject to the Company achieving specified annual performance goals.
(2)For the Company's Chief Executive Officer, 40% of the annual equity grant vests in equal quarterly increments and 60% is subject to the Company achieving specified annual performance goals.
Schedule Of Stock Option Activity
A summary of stock option activity under all of the Company’s plans is as follows:
 Options Outstanding
 Number of
Shares
Weighted
Average
Exercise Price
per Share
Balance, September 30, 2022164,796 $33.34 
Options granted2,051 4.55 
Options exercised(56,516)26.38 
Options cancelled(4,463)61.35 
Balance, September 30, 2023105,868 $35.31 
Schedule Of Outstanding Stock Options Currently Exercisable, Vested And Expected To Vest
A summary of options outstanding that are exercisable and that have vested and are expected to vest as of September 30, 2023 is as follows:
Number of
Shares
Weighted
Average
Remaining
Contractual
Life (in Years)
Weighted
Average
Exercise
Price
per Share
Aggregate
Intrinsic
Value(1)
 (In thousands)
Stock options outstanding105,868 5.62$35.31 $13,321 
Exercisable99,067 5.54$35.47 $12,449 
Vested and expected to vest105,561 5.61$35.36 $13,277 
(1)Aggregate intrinsic value represents the difference between the fair value of the Company’s common stock underlying these options at September 30, 2023 and the related exercise prices.
Schedule Of Equity Based Awards (Including Stock Options And Restricted Stock Units)
As of September 30, 2023, equity based awards (including stock options and restricted stock units) are available for future issuance as follows:
 Awards
Available for
Grant
Balance, September 30, 20222,072,778 
Granted(1,629,873)
Cancelled349,715 
Additional shares reserved (terminated), net4,504,183 
Balance, September 30, 20235,296,803